Baar, Switzerland

Oliver Bludau

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Oliver Bludau

Introduction

Oliver Bludau is a notable inventor based in Baar, Switzerland. He has made significant contributions to the field of medical technology, particularly in the modeling of coronary circulatory systems. His work focuses on addressing critical issues related to microvascular obstruction in patients.

Latest Patents

Oliver Bludau holds a patent for a "Microfluidic Coronary Circulatory Model." This innovative system is designed to model microvascular obstruction (MVO) in patients. The multi-scale model mimics myocardial microcirculation of coronary vessels and includes collaterals that provide alternative pathways to bypass MVO. It also models coronary artery compliance for spatially resolved fluid transport through the coronary vessels. The model simulates MVO by increasing flow resistance in one or more of the modeled coronary vessels or by completely blocking them. Additionally, it mimics fluid transport behavior during diagnostics or treatment, aiding in the design and optimization of therapy protocols for MVO.

Career Highlights

Oliver Bludau is currently associated with Corflow Therapeutics AG, where he continues to develop innovative solutions in the medical field. His expertise in microfluidics and coronary circulation has positioned him as a key player in advancing therapeutic protocols for cardiovascular conditions.

Collaborations

Some of his notable coworkers include Andre Bernard and Peter Heeb, who contribute to the collaborative efforts at Corflow Therapeutics AG.

Conclusion

Oliver Bludau's work in developing a microfluidic coronary circulatory model showcases his commitment to improving patient outcomes in cardiovascular health. His innovative approach and collaboration with talented colleagues highlight the importance of teamwork in advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…